Dr. Gronvall is a Senior Associate at the Johns Hopkins Center for Health Security and Visiting Faculty at the Johns Hopkins Bloomberg School of Public Health. She is the author of the book Synthetic Biology: Safety, Security, and Promise, published in fall 2016 (Health Security Press). While the synthetic biology discipline is poised to revolutionize important sectors for national security, there are technical and social risks. Dr. Gronvall describes what can be done to minimize risks and maximize the benefits of synthetic biology, focusing on biosecurity, biosafety, ethics, and US national competitiveness. Dr. Gronvall is also the author of the book Preparing for Bioterrorism: The Alfred P. Sloan Foundation’s Leadership in Biosecurity. She serves on several committees, including the National Academies' Committee on Strategies for
Identifying and Addressing Biodefense Vulnerabilities Posed by Synthetic Biology, and the Threat Reduction Advisory Committee (TRAC), which provides the Secretary of Defense with independent advice and recommendations on reducing the risk to the United States, its military forces, and its allies and partners posed by nuclear, biological, chemical, and conventional threats. Dr. Gronvall received a BS in biology from Indiana University, Bloomington, subsequently worked as a protein chemist at the Memorial Sloan-Kettering Cancer Center, and received a PhD from Johns Hopkins University for work on T-cell receptor/MHC I interactions.She was a National Research Council Postdoctoral Associate at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fort Detrick, Maryland.